Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Birrer

Showing results (161-170 of 222) with videos related to

Pageof 23
Sort By:
The New England Journal of Medicine|March 3, 2016
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian CancerJohn K Chan, Mark F Brady, Richard T Penson, et al.
Nature Communications|December 20, 2017
Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancerRuogu Qi, Yongheng Wang, Peter M Bruno, et al.
Nature Communications|April 19, 2020
Author Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancerRuogu Qi, Yongheng Wang, Peter M Bruno, et al.
JAMA Oncology|February 6, 2016
Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian CarcinomaElizabeth M Swisher, Maria I Harrell, Barbara M Norquist, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2021
Sex Hormones, Insulin, and Insulin-like Growth Factors in Recurrence of High-Stage Endometrial CancerMelissa A Merritt, Howard D Strickler, Alan D Hutson, et al.
Nature Communications|February 9, 2018
Publisher Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancerRuogu Qi, Yongheng Wang, Peter M Bruno, et al.
International Journal of Molecular Epidemiology and Genetics|May 3, 2011
A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studiesKathryn L Terry, Allison F Vitonis, Dena Hernandez, et al.
Head & Neck|November 3, 2021
Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522Elaine O Bigelow, Jonathan Harris, Carole Fakhry, et al.
Cell Reports|April 4, 2019
Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular VesiclesMikołaj Piotr Zaborowski, Kyungheon Lee, Young Jeong Na, et al.
Molecular Therapy. Nucleic Acids|June 29, 2026
Detection of mutant cancer-derived circRNAs in extracellular vesicles by rolling circle amplificationMikołaj Piotr Zaborowski, Charles Pin-Kuang Lai, Alessandro Sammarco, et al.
Pageof 23

Showing results (161-170 of 222) with videos related to

Sort By:
Pageof 23
The New England Journal of Medicine|March 3, 2016
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian CancerJohn K Chan, Mark F Brady, Richard T Penson, et al.
Nature Communications|December 20, 2017
Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancerRuogu Qi, Yongheng Wang, Peter M Bruno, et al.
Nature Communications|April 19, 2020
Author Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancerRuogu Qi, Yongheng Wang, Peter M Bruno, et al.
JAMA Oncology|February 6, 2016
Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian CarcinomaElizabeth M Swisher, Maria I Harrell, Barbara M Norquist, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2021
Sex Hormones, Insulin, and Insulin-like Growth Factors in Recurrence of High-Stage Endometrial CancerMelissa A Merritt, Howard D Strickler, Alan D Hutson, et al.
Nature Communications|February 9, 2018
Publisher Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancerRuogu Qi, Yongheng Wang, Peter M Bruno, et al.
International Journal of Molecular Epidemiology and Genetics|May 3, 2011
A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studiesKathryn L Terry, Allison F Vitonis, Dena Hernandez, et al.
Head & Neck|November 3, 2021
Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522Elaine O Bigelow, Jonathan Harris, Carole Fakhry, et al.
Cell Reports|April 4, 2019
Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular VesiclesMikołaj Piotr Zaborowski, Kyungheon Lee, Young Jeong Na, et al.
Molecular Therapy. Nucleic Acids|June 29, 2026
Detection of mutant cancer-derived circRNAs in extracellular vesicles by rolling circle amplificationMikołaj Piotr Zaborowski, Charles Pin-Kuang Lai, Alessandro Sammarco, et al.
Pageof 23